The in vivo relevance of these findings was demonstrated in xenograft models, where co‐injection of mDia2 knock‐down fibroblasts with SCC cells overexpressing activin A strongly diminished the potent effect of activin A on tumor growth and progression. The gene discussed is DIAPH3; the disease is neoplasm.